Relationship of Addictions to Obesity, Physical Activity & Vascular Ageing

Status Recruiting

Clinical Trial Summary

This is a cross-sectional observational study whose objective is to analyse the relationship between behavioural addictions and drug addictions with obesity, physical activity, sedentary lifestyle, arterial stiffness and vascular ageing in young adults, since many of the lifestyles of adulthood are established early in life, and it is easier to prevent them before they start than to achieve their abandonment once they are established as unhealthy lifestyles

Clinical Trial Description

Behavioural addictions. Brief Questionnaire of Pathological Gambling (CBJP), Lie/Bet scale, Compulsive Internet Use Scale (CIUS), Smartphone Dependence and Addiction Scale (EDAS-18), Questionnaire of Experiences Related to Video Games (CERV). Drug addictions: Alcohol, Smoking and Substance Involvement Screening Test (ASSIST V3.0), Drug Abuse Screening Test (DAST-20), Alcohol Use Disorders Identification Test (AUDIT) and Fagerström test. Obesity and body composition: Weight, height, waist circumference, hip circumference and Inbody 230®. Diet: Mediterranean Diet Adherence Questionnaire. Physical activity: International Physical Activity Questionnaire (IPAQ), Actigraph GTX3 accelerometer and Marshall questionnaire. Analysis of vascular structure and function and target organ lesions. Pulse wave analysis (PWA) and femoral carotid pulse wave velocity (VOPcf) (Sphygmocor System). Cardio Ankle Vascular Index (CAVI), ankle-ankle pulse wave (VOPbt) and ankle-ankle index (ABI) (Vasera VS-2000®). Retinal vascular injury (TOPCON TRC NW 200). Cardiac lesion (General electric 5000). Kidney Injury: analytical variables. Brain Injury: Montreal Cognitive Assessment (MoCA). Vascular ageing (VOPcf and VOPbt). Other variables. Basal glycaemia, HbA1c. TSH, lipid profile, creatinine and creatinine albumin index and Vit D. Measurement of blood pressure and drug consumption. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05866133
Study type	Observational
Source	Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Contact	Manuel A Gomez-Marcos, Dr
Phone	923291100
Email	magomez@usal.es
Status	Recruiting
Phase
Start date	April 17, 2023
Completion date	March 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02939352` - The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues	Early Phase 1
Completed	`NCT02192931` - A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users	Phase 4
Completed	`NCT02437123` - The Cedar Project: Impact of mHealth for HIV Prevention Among Young Indigenous People Who Use Illicit Drugs	N/A
Completed	`NCT02282306` - Phone Interview to Prevent Recurring Opioid Overdoses	N/A
Completed	`NCT02224508` - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks	N/A
Completed	`NCT01685073` - The Role of Sleep in the Treatment of Cannabis Use Disorders	Phase 2/Phase 3
Completed	`NCT01591239` - Home-Based Program to Help Parents of Drug Abusing Adolescents	N/A
Completed	`NCT00317460` - Buprenorphine and Integrated HIV Care	Phase 4
Completed	`NCT03678051` - CBT4CBT for Women in Residential Treatment for Substance Use Disorders	N/A
Completed	`NCT04105621` - Westlake Personalized Nutrition and Health Cohort for Drug Addicts
Withdrawn	`NCT05440721` - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification	N/A
Completed	`NCT03694327` - Innovative Digital Therapeutic for Smoking Cessation	N/A
Completed	`NCT00244699` - Integrating Mindfulness-Based Skills Training Into Brief Outpatient Treatment for Substance Abusing Youth	N/A
Completed	`NCT00496990` - Treating the Partners of Drug Using Pregnant Women: Stage II	Phase 2/Phase 3
Completed	`NCT00390559` - Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3	N/A
Completed	`NCT03402672` - AWAITS: A Web-based E-health Application for Active Illicit Opioid Users	N/A
Completed	`NCT03411265` - RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing	N/A
Completed	`NCT01003496` - Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial	Phase 3
Completed	`NCT02091284` - Bilateral Prefrontal Modulation in Alcoholism	N/A
Completed	`NCT02091167` - Bilateral Prefrontal Modulation in Crack-cocaine Addiction	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Relationship of Addictions to Obesity, Physical Activity and Vascular Ageing in Young Adults

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms